FunPep Company Limited (TSE: 4881)
Health Care · Biotechnology · JP
¥45.00
+2.27% today · -56.7% 1Y
FunPep Company Limited (TSE: 4881) operates in the Biotechnology industry within the Health Care sector. The company is valued at $14.44M and employs 15 people.
Over the last twelve months the share price has lost 56.7%, trading between 42.00 and 130.00.
Tweenvest scores FunPep Company Limited across four factors: quality 48/100, value 15/100. Its strongest factor is quality.
4881 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $14.44M
- Revenue (TTM)
- $6.15K
- P/E
- —
- EPS
- -37.08
- Dividend yield
- —
- Beta (5Y)
- 0.84
- 52-week high
- ¥130.00
- 52-week low
- ¥42.00
- Avg volume (3M)
- —
- Shares outstanding
- 50.67M
- Employees
- 15
- Next earnings
- —
About FunPep Company Limited
FunPep Company Limited specializes in the discovery and advancement of pharmaceutical drugs, functional cosmetics, and medical devices, leveraging its core technology in functional peptides. The company's development pipeline prominently features SR-0379, a functional peptide designed to address skin ulcers. FunPep is advancing FPP003, an antibody-inducing peptide, which is undergoing Phase II clinical trials for psoriasis in Australia and for ankylosing spondylitis in Japan. Another antibody-inducing peptide, FPP004X, is also in development, targeting pollinosis. Additionally, the company is working on FPP006, a corona peptide vaccine, and FPP005, an antibody-inducing peptide for psoriasis. Established in 2013, FunPep Company Limited operates from its headquarters in Tokyo, Japan.
- ISIN
- JP3802640007
- Founded
- 2013
- Listed since
- Dec 25, 2020
- Exchange
- The Tokyo Stock Exchange
- Currency
- JPY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Valbiotis SAENXTPA: ALVAL | $14.66M | €0.55 | +3.36% |
| Poongjeon Pharmacy CO.,LTD.KOSDAQ: A298060 | $14.56M | ₩2,195.00 | -5.39% |
| Actuate Therapeutics, Inc.NasdaqGM: ACTU | $14.53M | $0.61 | -0.85% |
| Initiator Pharma A/SOM: INIT | $14.45M | Skr2.09 | +16.11% |
| NewcelX Ltd.NasdaqCM: NCEL | $14.44M | $2.50 | -17.90% |
| Aptamer Group PLCAIM: APTA | $14.29M | £0.00 | -4.62% |
| Allarity Therapeutics, Inc.NasdaqCM: ALLR | $14.24M | $0.90 | -9.60% |
| Abera Bioscience ABNGM: ABERA | $14.09M | Skr— | — |
Figures last refreshed Oct 18, 2026.